Elizabeth Kelvin is an Associate Professor in the Department of Epidemiology and Biostatistics at the CUNY Graduate School of Public Health and Health Policy (SPH).
She is also a Researcher at the CUNY Institute for Implementation Science in Population Health and the CUNY SPH Center for Immigrant, Refugee and Global Health, and a member of the Data Core of the Pandemic Response Institute. She holds additional appointments as an Adjunct Associate Professor at Hofstra University/North well Health and Honorary Research Scientist at the University of Alcala in Spain. She is an infectious disease epidemiologist by training, an interest that began while serving as a US Peace Corps Volunteer in Paraguay. Dr. Kelvin also spent a year teaching English in South Korea, was the Teaching Assistant for Epidemiology and Biostatistics course for the inaugural cohort of MPH students at BRAC University in Bangladesh, and she spent a semester during college at the Universidad Autónima de México in Mexico City. She speaks English and Spanish.Her research has focused on infectious diseases, primarily in low- and middle-income countries. She was the Project Director of a randomized controlled trial (RCT) evaluating albendazole treatment for patients with neurocysticercosis (NCC) conducted in Ecuador (NINDS R01-NS39403, PI: Hauser) that was considered one of only two high quality trials on NCC treatment by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH) (See: https://academic.oup.com/cid/article/66/8/e49/4885412?login=false). She was the Principal Investigator (PI) on a grant trying to understand the variation in the evolution and reaction to treatment of NCC parasitic cysts even within the same person (NINDS 1R03NS111189-01A1) and a study looking at the potential to study NCC and other neglected diseases, within the United States (PSC CUNY 65469-00 53). She has also conducted a number of studies on HIV/STI risk, prevention, testing and treatment in Asia and Africa, and was the PI for three RCTs evaluating the impact of adding oral HIV self-testing (HIVST) as an HIV testing option in a roadside clinic system in Kenya that serves truck drivers, sex workers and roadside communities. The HIVST studies were conducted in consultation with the National AIDS and STIs Control Program (NASCOP) at the Kenya Ministry of Health to help inform their policy on HIV self-testing and soon after these and other related studies in Kenya were completed, HIV self-test kits were approved for use in Kenya. Dr. Kelvin currently runs a lab on Neglected and Emerging Infectious Diseases (NEID) made-up of students and faculty working on related research projects. Dr. Kelvin has published over 95 manuscripts in peer review journals and co-edited a statistics textbook. For a complete list of her publications, see: https://scholar.google.com/citations?hl=en&user=FmDX4PAAAAAJ&view_op=list_works&sortby=pubdate.
Degrees
PhD in Epidemiology from Columbia University, New York, NY
MPhil in Epidemiology from Columbia University, New York, NY
MPH in Epidemiology from Columbia University, New York, NY
MA in Latin American Studies from Tulane University, New Orleans, LA
BA in Psychology from University of Chicago, Chicago, IL
Research Interests
Infectious Disease Epidemiology, HIV/AIDS, STIs, Neurocysticercosis, Neglected and Emerging Diseases, Global Health, Randomized Controlled Trials (RCTs)